Trademark Details For KEEVENLY (Serial Number 97110303)

  •  Home
  •  Print
KEEVENLY
  • Rank
    Global Trademark Influence Ranking
    3398
0
0
0
0
Serial Number  United States - USPTO 97110303
Registration Number -
Mark
KEEVENLY
Filing Date Nov-05-2021
Status
Pending  
FIRST EXTENS.. (730)
FIRST EXTENSION - GRANTED
Attorney Name
TTAB1
Action Tags
  




005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameLaurence Rickles
AddressTEVA PHARMACEUTICALS USA, INC. 400 INTERPACE PARKWAY BUILDING A PARSIPPANY,NJ 07054

Prosecution History

  
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Dec-22-2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Dec-20-2023SOU EXTENSION 1 GRANTED   EX1GS
Dec-20-2023SOU EXTENSION 1 FILED   EXT1S
Dec-20-2023SOU TEAS EXTENSION RECEIVED   EEXTI
Jun-27-2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
May-17-2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED   ETOPT
May-11-2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED   CHPBI
May-11-2023ASSIGNED TO PETITION STAFF   APETA
Apr-21-2023TEAS POST PUBLICATION AMENDMENT RECEIVED   EPPAI
Apr-06-2023EXTENSION OF TIME TO OPPOSE RECEIVED   ETOFT
Mar-07-2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Mar-07-2023PUBLISHED FOR OPPOSITION   PUBOA
Feb-15-2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Jan-30-2023APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Jan-30-2023SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION   RCCKS
Dec-06-2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED   ERSII
May-25-2022
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
  
GNS3O
May-25-2022LETTER OF SUSPENSION E-MAILED   GNSLF
May-25-2022SUSPENSION LETTER WRITTEN   CNSLR
May-25-2022ASSIGNED TO EXAMINER   DOCKD
Nov-15-2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Nov-09-2021NEW APPLICATION ENTERED   NWAPI